Measuring system for invasive coronary physiology measurements, hydrostatic pressure change compensation device, and method thereof
The system addresses hydrostatic pressure discrepancies by adjusting the transducer position in real-time, providing accurate FFR and hemodynamic parameter measurements without post-processing, ensuring reliable clinical decision-making.
Patent Information
- Application Number
- PCT/HU2026/050040
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-04-28
- Publication Date
- 2026-11-12
AI Technical Summary
Current FFR measurement systems fail to accurately account for hydrostatic pressure differences between the transducer located outside the body and the sensor within the coronary artery, leading to distorted pressure ratio calculations and inaccurate treatment recommendations.
A system and method that compensates for hydrostatic pressure differences by adjusting the position of the transducer in real-time using a linear actuator, ensuring that pressure measurements are taken at physically identical locations, thereby correcting the pressure ratios.
Enables accurate, real-time correction of FFR and other hemodynamic parameter measurements, eliminating the need for post-processing and ensuring reliable prognostic data during invasive coronary physiology assessments.
Smart Images

Figure HU2026050040_12112026_PF_FP_ABST
Abstract
Description
[0001] Measuring system for invasive coronary physiology measurements, hydrostatic pressure change compensation device, and method thereof
[0002] The subject of the invention is a measuring system for invasive coronary physiology measurements, in particular for measuring coronary fractional flow reserve or other hemodynamic parameters, comprising a guide catheter having a proximal end, a distal end extendable through the aorta to a coronary ostium, and a lumen that can be filled with a fluid column, a pressure transducer connectable to the fluid column via the proximal end of the guide catheter, and a pressuremeasuring guidewire equipped with a pressure sensor that can be advanced into the coronary artery through the lumen of the guide catheter.
[0003] The subject matter of the invention is further a hydrostatic pressure change compensating device for invasive coronary physiology measurements, particularly for coronary fractional flow reserve measurement.
[0004] The subject matter of the invention is further a method for compensating for hydrostatic pressure in invasive coronary physiology measurements, particularly for coronary fractional flow reserve measurements, using such system and device.
[0005] Background Art
[0006] Vascular diseases often manifest as reduced blood flow in blood vessels, for example the coronary arteries of the heart, due to atherosclerotic stenosis. In clinical practice, one of the hemodynamic parameters used to characterize the degree (severity) of vascular narrowing for prognostic purposes is the so-called fractional flow reserve (FFR) and the so-called coronary flow reserve (CFR). The FFR value is the ratio of the pressure measured at a point in the coronary artery located downstream of the site of stenosis (the so-called distal position) to the pressure prevailing / measured in the aorta (proximal position) in the state of maximum vasodilation. By measuring this pressure ratio, FFR indicates the extent to which blood flow is reduced in the affected vessel due to the stenosis. The CFR value is the ratio of the flow (or its velocity) measured in one of the coronary arteries under conditions of maximal vasodilation (“hyperemia”) to the flow (or its velocity)measured in that coronary artery at rest, and characterizes the flow capacity of the entire coronary artery system, essentially. Maximal vasodilation is generally achieved through the use of various vasodilators. The pressures mentioned above are measured, as is known, using pressure measuring guidewires introduced invasively into the coronary arteries or into the aorta (intracoronary direct pressure measurement). Similarly, the flow velocities required to derive the CFR value can be determined directly, for example with catheterization, using intravascular ultrasound examination (using a Doppler probe).
[0007] In clinical practice, the selection of an appropriate treatment method (i.e., drug therapy, stent implantation, or coronary artery bypass surgery) for atherosclerotic coronary artery disease is currently based primarily on the FFR value, which characterizes the physiological state of the coronary arteries. When making this decision, coronary angiography, which reveals the anatomical condition of the coronary arteries, and its imaging results are also taken into account as an independent prognostic tool and in the form of an independent analysis.
[0008] In FFR patients, the value determined as described above characterizes the stenosis of the coronary arteries and the restriction of blood flow within the vessel based on pressure measurement and pressure ratio. An FFR value below 0.80 — based on experience — indicates significant restriction of blood flow, and according to current clinical guidelines, it justifies stent implantation to reduce or eliminate the stenosis. The FFR measurement procedure is thus serves to determine what actual change a stenosis visible on angiography causes in blood flow, and whether catheter-based vasodilation is necessary in the given vessel segment.
[0009] In the case of CFR patients, the value determined as described above, based on flow velocity measurement and ratio, characterizes the degree of coronary artery stenosis and the restriction of blood flow within the vessel in relation to the total coronary artery system ( ). A CFR value below 2.0 — based on experience — indicates insufficient blood supply to the myocardium and thus coronary artery occlusion. One drawback of using the CFR value for prognostic purposes is that the insertion of the Doppler probe requires an invasive surgical procedure, and the measurement itself is technically complex (to ensure a high-quality flow velocity profile, the Doppler probe must be kept in the correct position throughout themeasurement) and costly.
[0010] The reliability of using CFR and FFR values for prognostic purposes is further complicated by the fact that, in some patients, the degree of stenosis differs based on the CFR and FFR values determined in their cases, meaning that different treatment approaches would be warranted based on the two values. This also underscores the importance of a comprehensive description and consideration of the pathophysiology of the stenosis (assessed from both pressure and flow perspectives) when selecting a treatment modality.
[0011] Due to the technical limitations of direct flow measurement mentioned above, numerous experiments have been conducted to simultaneously determine pressure-derived CFR (or CFRp) and FFR. One such approach is described, for example, in the paper by E. Shalman et al. titled “Pressure-based simultaneous CFR and FFR measurements: understanding the physiology of a stenosed vessel” (Comput. Biol. Med., September 2001 , 31(5), pp. 353-363), as well as U.S. patent applications No. US2003 / 0032886A and No. US2014 / 0276137. These documents postulate a quadratic relationship between the magnitude of the pressure drop (Ap) across the stenosis and blood flow (Q) in the form Ap ~Q2, from which the
[0012]
[0013] where pavand paare the proximal coronary pressures (measured in the aorta) in the hyperemic and resting states, respectively, while pdvand p are the distal coronary pressures in the hyperemic and resting states, respectively.
[0014] The calculation of the FFR measurement is based on the pressure value (Pa) of the fluid column in the catheter placed at the entrance to the coronary artery and the pressure value (Pd) measured by a sensor-equipped guidewire placed beyond the stenosis. The FFR value is determined by the following ratio:
[0015] FFR = - Pa
[0016] where:
[0017] Pa is the pressure before the stenosis (proximal pressure),
[0018] Pd is the pressure beyond the stenosis (distal pressure),
[0019] Both values are measured under conditions of maximal hyperemia(pharmacological vasodilation, e.g., administration of adenosine).
[0020] The following main components are used for the test:
[0021] Guide catheter: typically 6F in diameter, inserted into the coronary ostium (e.g., the ostium of the left coronary artery) via the femoral or radial artery. The proximal end of the catheter is connected to an external pressure sensor (transducer).
[0022] Pressure wire: typically a 0.014-inch diameter, sensor-equipped, flexible wire that is advanced to the distal side of the coronary stenosis.
[0023] External pressure sensor (transducer): part of a fluid-filled pressure measurement system connected to the guide catheter, used to determine the Pa value. It converts the pressure of the fluid column within the guide catheter into an electrical signal, which is typically displayed on an external monitor for the physician performing the procedure. The transducer is typically placed outside the patient’s body, at the level of the heart. However, conventional FFR measurement systems are unable to account for height differences of up to 5 cm in the coronary arteries with greater precision.
[0024] During FFR measurement, a guide catheter is inserted into the patient’s arterial system and positioned at the opening of the target coronary artery. The guidewire containing the pressure sensor is advanced through the catheter past the coronary stenosis. Pharmacological hyperemia is induced (usually by intravenous or intracoronary administration of adenosine). The system simultaneously records the proximal (Pa) and distal (Pd) pressure values.
[0025] Based on the measured values, the system typically automatically calculates the FFR and assesses whether the stenosis is hemodynamically significant (generally accepted cutoff: FFR < 0.80).
[0026] One known problem with currently used measurement methods is that the transducer determining the Pa value is located outside the patient’s body, while the sensor measuring the Pd value is located within a coronary artery of the heart, often either above or below the plane of the catheter tip measuring Pa. Consequently, the hydrostatic pressure difference between the two measurement points can distort the FFR value, as pointed out, for example, by Aron Uveges et al. in their article “The impact of hydrostatic pressure on the result of physiology measurements in various coronary segments” (Springer, The International Journal of Cardiovascular Imaging,published online: August 17, 2020) Based on 3D and 2D coronary artery reconstructions performed using invasive angiographic images, the authors investigated how to determine the height difference causing the hydrostatic pressure error between the catheter tip measuring aortic pressure and the pressure sensor. The authors found that the effect of hydrostatic pressure on the 0.80 FFR cutoff value can be significant in different coronary segments. In the study population (41 lesions, with FFR measurements ranging from 0.7 to 0.9), correction for the height difference of the pressure sensor altered the interpretation of the FFR measurement (0.80 threshold) (in terms of negative / positive results), while for the resting Pd / Pa ratio (0.92 threshold), this occurred in 11 cases (27%).
[0027] The post-hoc correction used in the article is of little practical use in assisting the examining physician, who needs to view accurate measurement data in real time during the examination.
[0028] Hungarian patent application No. P1800091 proposes a method involving a 3D reconstruction based on a coronary angiography procedure (coronary angiography), and by combining the data obtained from this imaging with pressure data from FFR measurements performed simultaneously with the coronary angiography on the patient, reliable prognostic predictors can be derived based on general fluid flow laws. However, this method is still not suitable for providing adequate pressure measurement data in real time during FFR measurements to ensure an unbiased determination of FFR.
[0029] It is a well-researched and published field to determine which height differences in the coronary arteries lead to which pressure differences; however, without the specific anatomy of the given patient, general knowledge cannot be applied, or can only be applied to a limited extent . Current knowledge is also of no help when pressure values in the vessel are measured by continuously examining multiple narrowings in a long, irregular vascular segment using the so-called “pullback” procedure.
[0030] The objective of the invention is to provide a device, system, and method that is free from the disadvantages of solutions known in the background art.
[0031] It is recognized by the inventors of the present invention that, in currently used systems, the display of actual values is possible only through the simultaneous, immediate hydrostatic pressure correction of the pressure curveobtained via the pressure measuring guidewire. The inventors recognized that the hydrostatic pressure difference resulting from the height level of the pressure sensor can be physically compensated in real time by adjusting the position of the transducer measuring aortic pressure (Pa) in accordance with the height level of the pressure sensor.
[0032] The problem was solved by the system according to claim 1 , the device according to claim 10, and the method according to claim 15 of the invention.
[0033] The system, device, and method of the invention are particularly suitable for measuring coronary fractional flow reserve or other hemodynamic parameters. Such other hemodynamic parameters include, for example, the aforementioned CFR, as well as RRR (Resistive Reserve Ratio) and MRR (Microvascular Resistance Reserve).
[0034] Certain advantageous embodiments of the invention are defined in the claims.
[0035] Further details of the invention are described with construction examples and drawings. The drawing in
[0036] Figure 1 is a schematic image of a measuring system according to the invention,
[0037] Figure 2 is a schematic image illustrating the use of the measuring system according to the invention, and
[0038] Figure 3 is a schematic image of a guidewire equipped with a pressure sensor inserted into a coronary artery,
[0039] Figure 4 is a schematic image illustrating the pressure conditions resulting from the positions of the aorta and the coronary artery,
[0040] Figure 5 is an angiographic image illustrating the position of the coronary arteries,
[0041] Figure 6 is a schematic diagram illustrating the spatial dependence of pressure ratios measured in different coronary arteries.
[0042] Figures 1-2 show the main components of a measuring system according to the invention. The measuring system 100 can be used for invasive coronary physiology measurements, particularly for measuring coronary fractional flow reserve. The measuring system 100 comprises a guide catheter 10, having a proximal end 11 and a distal end 12 that can be advanced through the aorta to acoronary ostium (see Figure 2). The lumen of the guide catheter 10 is filled with a fluid column, such as a sterile heparinized saline solution.
[0043] The measuring system 100 comprises a transducer 20 that can be connected to the fluid column via the proximal end 11 of the guide catheter 10; the fluid column transmits the aortic pressure to the transducer 20, which is measured by the transducer 20. If the transducer 20 is not directly connected to the proximal end 11 of the guide catheter 10, they are connected by a fluid-filled conduit.
[0044] The measuring system 100 preferably includes a manifold 30 through which the transducer 20 can be connected to the proximal end 11 of the guide catheter 10.
[0045] The measuring system 100 includes the pressure measuring guidewire 40 that can be guided into the coronary artery through the lumen of the guide catheter 10, with a pressure sensor 42, typically a semiconductor sensor, located near its distal end.
[0046] The measuring system 100 further comprises a linear actuator 50 and a control system 60, which are used to compensate for the hydrostatic pressure difference resulting from the relative position of the sensor 42 with respect to the distal end 12 of the guide catheter 10. The linear actuator 50 and control system 60 are components of a hydrostatic pressure compensation device according to the invention, which, in the case of the invention, is combined with a conventional FFR measurement system to form the measurement system 100 according to the invention.
[0047] The linear actuator 50 may, for example, be an actuator operated by a stepper motor or a lead screw mechanism.
[0048] The control system 60 is preferably connected to the display 70, which is used to display in real time the pressure values (Pd, Pa) measured by the pressure sensor 42 and the pressure transducer 20, as well as the FFR or Pd / Pa ratios calculated from them. The control system 60 may, for example, be a computer that may have additional input and output peripherals (such as a keyboard, mouse, etc.), as will be apparent to those skilled in the art.
[0049] In one preferred embodiment, the measuring system 100 is connected to an angiographic X-ray imaging device 80.
[0050] For FFR measurement, the measuring system 100 preferably includes a motorized guidewire retraction unit 90, which is a known, commercially availabledevice.
[0051] Below, we describe FFR measurement performed using the measuring device 100 according to the invention and the hydrostatic pressure compensation device that forms part of it.
[0052] The pressure measurement reference level of the measuring system 100 was set at the distal end 12 of the guide catheter 10. Aortic pressure was measured here, and the equalization adjustment of the aortic pressure measured by the pressure sensor 42 and the pressure transducer 20 was also performed in this position.
[0053] When the pressure sensor 42 of the pressure-measuring wire is advanced into the distal segment of the left anterior descending artery (LAD), a hydrostatic pressure drop occurs relative to the reference level due to the difference in elevation. In contrast, hydrostatic pressure increases toward the distal portion of the left circumflex artery (LCx). It is important to note that these hydrostatic pressures do not contribute to the driving force of blood flow, since at the same level, hydrostatic pressures in the venous system are equal to those measured in the arterial system. However, when measuring epicardial pressure gradients and assessing microvascular resistance, these hydrostatic pressure variations will have a significant effect.
[0054] During the measurement, the patient 1 lies supine on a table 200, which may be part of the system 100 or an external device. In this case, the pressure difference measured between the tip of the guide catheter 10 and the pressure sensor 42 located distally from the two stenoses (see Figure 3) consists of two components, namely the pressure loss caused by the pressure flowing through the stenoses 2 and the hydrostatic pressure difference measured between the end 12 of the guide catheter 10 (i.e. , the origin of the coronary artery) and the level of the distal intracoronary pressure sensor 42 (Figure 4). This latter component can be referred to as hydrostatic shift (AP hydrostatic pressure), and since it modifies the distal pressure value, it also influences the measured pressure difference values.
[0055] In Figure 4, we converted the measured height difference to mm Hg, which gives the hydrostatic pressure error (red). In this case, this value is 5.58 mm Hg, based on 0.77 mm Hg per 1 cm of height difference. (In calculating the hydrostatic pressure effect, we assumed a blood density of 1050 kg / m3.) This hydrostaticpressure error significantly influences the pressure difference measured at the tip of the guide catheter 10 and detected by the pressure sensor 42 of the pressuremeasuring wire, and has a significant impact on the results of both the FFR and Pd / Pa calculations (as well as the results of the CFR calculation). In the formula shown in Figure 4:
[0056] AP: pressure drop in the distal direction of the coronary artery;
[0057] Q: volumetric flow;
[0058] s: quadratic coefficient in the term related to separation;
[0059] APhydrostatic: hydrostatic pressure difference;
[0060] f: linear coefficient in the viscous friction pressure loss.
[0061] The physical correction of distal pressure to hydrostatic pressure (Pd corn) is based on the elevation differences between the origin of the coronary artery and the distal coronary segments.
[0062] According to Pascal’s law, the hydrostatic pressure measurable in the coronary arteries is 0.077 mmHg per millimeter, calculated using the average density of blood (1050 kg / m3). Studies using CT coronary angiography have described the pressure differences between the anterior and posterior coronary regions in the supine position.
[0063] In the angiographic images 82 taken from the lateral projection, the height difference between the orifice and the sensor is depicted without distortion. To compute the height difference measurable from this view (2D-based), the X-ray machine’s built-in calculation program was used. In a supine patient, the sternum is visible on the left side of the screen, so the height difference can be measured horizontally (see Figure 5). In Figure 5, the level difference between the distal segments of the LAD and CX and the tip of the pressure-measuring catheter in the aorta is obtained in the “horizontal” direction from the projection taken in the lateral position (LAD: left anterior descending artery; CX: left circumferential artery).
[0064] The height differences measured at the highest and lowest points of each vessel proved to be quite significant. In a previous study, intracoronary pressure measurements (resting Pd / Pa and FFR) were performed in both the standing and supine positions, and height differences were also determined based on CT images. These studies clearly found lower resting Pd / Pa and FFR values in the LADcompared to measurements taken in the CX or RCA (see Figure 6).
[0065] The hydrostatic pressure calculated based on the height difference is a constant parameter whose effect depends on general pressure conditions: it is more pronounced at low pressures. The direction of the effect depends on the position of the pressure-measuring wire sensor relative to the orifice of the measured vessel. If the sensor is positioned at a lower level than the reference level set (and equalized) at the tip of the catheter at the origin of the vessel being examined, the hydrostatic pressure resulting from the level difference is added to the pressure measured by the pressure wire. This situation typically occurs in the LCx. However, if, as is always expected with a pressure wire placed in the distal segment of the LAD, the sensor is positioned above the reference level, the measured distal pressure is reduced by the hydrostatic pressure. Since hydrostatic pressure in the arterial and venous systems does not differ at the level of the given vascular segment, it does not contribute to the pressure gradient that determines flow (driving pressure). Thus, when calculating the resting and hyperemic pressure ratios (Pd / Pa, FFR) used to assess the flow consequences of the stenosis, it would be appropriate to subtract the hydrostatic pressure from the distally measured pressure (with the appropriate sign).
[0066] During routine invasive coronary angiography, determining the height difference between the coronary orifice and the pressure sensor using 2D or 3D methods enables real-time correction of FFR and resting Pd / Pa measurements based on real-time hydrostatic pressure changes using the measuring system 100 and method of the invention, which eliminates the need for a post-calculated hydrostatic pressure correction of the measured distal pressure value.
[0067] In the method of the invention, the distal end 12 of the guide catheter 10 is therefore advanced through the aorta to a coronary ostium. The lumen of the guide catheter 10 is filled with a fluid column, and the pressure measuring guidewire 40 equipped with the pressure sensor 42 is introduced through the lumen of the guide catheter 10 via the distal end 12 of the guide catheter 10 into the coronary artery connected to the coronary ostium. We connect the fluid column in the guide catheter 10 to the pressure transducer 20 via the proximal end 11 of the guide catheter 10, which we secure to the linear actuator 50.
[0068] In the initial position, the transducer 20 is essentially set to the height levelof the distal end 11 of the guide catheter 10 using the linear actuator 50; however, the equalization step described later also allows for an offset to remain between the two levels. We insert the pressure measuring guidewire 40 through the guide catheter 10, but initially only until the sensor 42 reaches the distal end 12 of the guide catheter 10. Before further advancing the pressure measuring guidewire 40, we equalize the electrically detected pressure from the pressure sensor 42 and the fluid pressure measured at the tip of the guide catheter 10 by the transducer 20 by adjusting the electrical signal as needed. In this position, the Pa and Pd pressures are measured at physically identical locations, so theoretically Pa = Pd. The measuring system 100 uses this point to calibrate the measurement scale: the values from the transducer 20 and the pressure sensor 42 are then set to be identical.
[0069] Subsequently, the sensor 42 is advanced beyond the two stenoses in the coronary artery, and the measurement is first performed at the distal position.
[0070] In doing so, we determine the vertical displacement of the pressure sensor 42 relative to the initial position, which is the height level of the distal end 11 of the guide catheter 10 where the equalization took place. We adjust the vertical position of the pressure transducer 20 using the linear actuator 50 to the level corresponding to the vertical displacement of the pressure sensor 42. Subsequently, we measure the aortic pressure (Pa) with the transducer 20 while measuring the distal pressure (Pd) with the pressure sensor 42.
[0071] Preferably, based on X-ray fluoroscopy from the lateral projection, the height difference between the sensor 42 and the distal end 12 of the guide catheter 10 can be determined using the distance measurement software built into the X-ray equipment.
[0072] An additional alternative for determining the vertical position of the sensor 42 is for the control system 60 software to calculate the height difference — which appears on the screen and is measurable in pixels — with millimeter accuracy by calibrating it to the known diameter of the catheter (or by calibrating the measurement based on data stored in the DICOM image header).
[0073] Another option is to determine the vertical position of the sensor 42 based on the CT diagram of the coronary network and the length of the pressure measuring guidewire 40 inserted into the guide catheter 10.Based on the vertical displacement of the sensor 42, we adjust the vertical position of the pressure transducer 20 by controlling the linear actuator 50.
[0074] In one possible embodiment, the vertical position of the transducer 20 is adjusted so that the transducer 20 is exactly at the height of the sensor 42.
[0075] In another possible embodiment, the vertical position of the pressure transducer 20 is adjusted based on the ratio of the blood density to the density of the liquid forming the fluid column, according to the
[0076] Pi
[0077] h2= A / I-L —
[0078] P2
[0079] formula, where
[0080] / I-L is the vertical displacement of the pressure sensor relative to the initial position,
[0081] A / I2is the vertical displacement of the transducer to be set by the linear actuator relative to the transducer’s initial position,
[0082] i is the density of the blood,
[0083] p2the density of the fluid forming the fluid column.
[0084] Note that this is also an approximate method, since with this approach we added the same pressure (with a positive or negative sign) to the aortic pressure measured by the transducer 20; however, since FFR is a ratio, if we shift both the numerator and the denominator by the same value, the ratio does not remain constant and varies to a greater extent the more the numerator and denominator differ from each other. However, we found that the correction applied here eliminates the error resulting from hydrostatic pressure changes within the measurement error margin around the critical FFR value of 0.8. For example, if we measure a 5 cm height difference in the LAD between the tip of the catheter and the sensor, and without correction we measured Pd = 80 mmHg and Pa = 100 mmHg, Pd / Pa would be 0.8. However, by adjusting the transducer’s height, we can bring it to the same level as the sensor, and in this case, we will measure Pa as 100 - (5 x 0.77) = 96.15 mmHg, so FFR = 80 / 96 = 0.83. Thus, the height difference correction compensates for the error caused by the hydrostatic pressure drop and raises the pathological FFR value of 0.80 (without correction) to 0.83, which — unlike the uncorrected value — no longer constitutes an indication for stent implantation ( ).
[0085] At the same time, the present system and method accurately correct thedetermination of the Pa-Pd pressure gradient, because when calculating this difference, the measured aortic pressure changes exactly by the error in the measured Pd value, so the resulting difference becomes “true” (here, this does not refer to a ratio). This is important because when calculating pressure-based CFR and microvascular function (RRR, MRR), we use resting and hyperemic Pa-Pd values, and the error in these values due to hydrostatic pressure can cause the calculated CFR, RRR, and MRR values, as pointed out by Agoston Andras et al. in their article “The pressure-derived microvascular resistance reserve and its correlation to Doppler MRR measurement — a proof of concept study” (Front. Cardiovasc. Med., June 3, 2024. Sec. Coronary Artery Disease Volume 11 - 2024).
[0086] The measuring system 100 and method of the invention provide an immediate pressure curve correction solution, enabling currently used FFR measurement systems to display the actual pressure values and differences within the vessel without post-processing and independently of hydrostatic pressure.
[0087] As schematically illustrated in Figure 2, we generate a two-dimensional diagram 84 of the vertical and horizontal trends based on lateral image 82 of the given coronary artery. We then convert the horizontal axis into a time axis by aligning it with the retraction speed of the sensor 42 on the guidewire 40 inserted into the distal end of the coronary artery.
[0088] During the FFR measurement, we retract the pressure sensor 42 to the distal end of the guide catheter 10 using the motorized guidewire retraction unit 90, while continuously measuring distal pressure with the pressure sensor 42 and aortic pressure with the transducer 20, while adjusting the vertical position of the transducer 20 in real time using the linear actuator 50. The height change of the sensor 42 is also tracked by the dynamically moved transducer 20 outside the patient, based on the diagram 84.
[0089] The retraction of the guidewire 40 occurs at a constant speed or can be varied and adjusted based on anatomical conditions or medical feedback.
[0090] The pressure values (Pd, Pa) measured by the pressure sensor 42 and the transducer 20, as well as the FFR or Pd / Pa ratios calculated from them, are displayed in real time on the screen during retraction.
[0091] Some of the steps described above are performed using the control system 60.Accordingly, the control system 60 is configured to receive the height parameter determining the real-time vertical displacement of the pressure sensor, to determine the height adjustment parameter that defines the real-time adjustment of the transducer’s vertical position based on the height parameter, and to control the linear actuator in real time based on the height adjustment parameter.
[0092] The control system 60 is configured to determine the height parameter based on real-time coronary angiographic image 82 and / or to determine the height parameter based on a CT scan of the coronary network and the length of the guidewire inserted into the guide catheter.
[0093] The vertical position adjustment, which takes into account the density of the blood and fluid column, can also be calculated using the control unit 60.
[0094] It is clear that alternative solutions to the embodiments presented here are conceivable to those skilled in the art, which, however, fall within the scope of protection defined by the claims.
Claims
Patent claims1. The measuring system for invasive coronary physiology measurements, particularly for measuring coronary fractional flow reserve or other hemodynamic parameters, comprising a guide catheter with a proximal end and a distal end that can be advanced through the aorta to the coronary ostium, and a lumen that can be filled with a fluid column, a pressure transducer connectable to the fluid column via the proximal end of the guide catheter, a pressure-measuring guidewire equipped with a pressure-measuring sensor, which can be guided into a coronary artery through the lumen of the guide catheter, characterized in that a hydrostatic pressure compensation device comprising a linear actuator for changing the vertical position of the transducer, as well as a control system thatis configured to receive a height parameter that determines the real-time vertical displacement of the pressure sensor,is configured to determine a height adjustment parameter that defines the real-time adjustment of the transducer’s vertical position based on the height parameter, andis configured to control the linear actuator in real time based on the height adjustment parameter.
2. The measuring system according to claim 1 , characterized in that the control system is configured to determine the height parameter from a real-time coronary angiographic image.
3. The measuring system according to claim 1 , characterized in that the control system is configured to determine the height parameter based on a CT image of the coronary network and the length of the guidewire inserted into the guide catheter.
4. The measuring system according to any one of claims 1 to 3, characterized in that the control system is configured to determine the vertical position of the pressure transducer based on the ratio of blood density to the density of the fluid forming the fluid columnis configured in a manner determined by the formula, whereA / I-L is the height parameter, which specifies the vertical displacement of the pressure sensor relative to an initial position, / I2is the height adjustment parameter, which specifies the vertical displacement of the transducer to be adjusted by the linear actuator relative to the transducer’s initial position,i is the blood density,p2is the density of the fluid forming the fluid column.
5. The measuring system according to any one of claims 1 to 4, characterized in that it comprises an angiographic imaging system.
6. The measuring system according to any one of claims 1 to 5, characterized in that it comprises a motorized guidewire retraction unit.
7. The measuring system according to any one of claims 1 to 6, characterized in that it comprises a display for real-time visualization of pressure values (Pd, Pa) measured by the pressure sensor and the transducer, and FFR or Pd / Pa ratios or pressure gradients calculated therefrom, or other hemodynamic parameters calculated therefrom.
8. The measuring system according to any one of claims 1 to 7, characterized in that it comprises a manifold through which the transducer can be connected to the proximal end of the guide catheter.
9. The measuring system according to any one of claims 1 to 8, characterized in that the linear actuator is an actuator operated by a stepper motor or a lead screw mechanism.
10. The device for compensating for hydrostatic pressure changes in invasive coronary physiology measurements, particularly for measuring coronaryfractional flow reserve or other hemodynamic parameters, characterized in that it comprises a linear actuator for changing the vertical position of an aortic pressure transducer, as well as a control system for controlling the linear actuator based on the vertical displacement of a pressure sensor with a guidewire inserted into the coronary artery.
11. The device according to claim 10, characterized in that the control systemis configured to receive a height parameter determining the real-time vertical displacement of the pressure sensor,is configured to determine a height adjustment parameter that defines the real-time adjustment of the transducer’s vertical position based on the height parameter, andis configured to control the linear actuator in real time based on the height adjustment parameter.
12. The device according to claim 11, characterized in that the control system is configured to determine the height parameter from a real-time coronary angiographic image.
13. The device according to claim 11, characterized in that the control system is configured to determine the height parameter based on the CT image of the coronary network and the length of the guidewire inserted into the guide catheter.
14. The device according to any one of claims 11 to 13, characterized in that the control system is configured to determine the vertical position of the pressure transducer based on the ratio of blood density to the density of the fluid forming the fluid columnPih2= A / i-i —P2is configured in a manner determined by the formula, whereinA / I-L is the height is a parameter specifying the vertical displacement of thepressure sensor relative to a starting position,A / I2is the height adjustment parameter, which specifies the vertical displacement of the transducer to be adjusted by the linear actuator relative to the transducer’s initial position,i is the blood density,p2is the density of the fluid forming the fluid column.
15. Method for hydrostatic pressure compensation in invasive coronary physiology measurements, particularly for measuring coronary fractional flow reserve or other hemodynamic parameters, in whichthe distal end of a guide catheter is advanced through the aorta to the coronary ostium,the lumen of the guide catheter is filled with a fluid column,a pressure-measuring guidewire equipped with a pressure sensor is advanced through the lumen of the guide catheter from the distal end of the guide catheter into the coronary artery connected to the coronary ostium,the fluid column in the guide catheter is connected to a pressure transducer via the proximal end of the guide catheter,the pressure transducer is mounted on a linear actuator,the vertical displacement of the pressure sensor relative to an initial position is determined,the vertical position of the pressure transducer is adjusted using the linear actuator in accordance with the vertical displacement of the pressure sensor, and the aortic pressure is measured with the transducer while measuring the distal pressure with the pressure sensor.
16. The method according to claim 15, characterized in that a real-time coronary angiographic image is acquired from the chest, and the vertical displacement of the pressure sensor relative to the initial position is determined therefrom.
17. The method according to claim 15, characterized in that the vertical displacement of the pressure sensor relative to the initial position is determined fromthe CT image of the coronary network and the length of the guidewire inserted into the guide catheter.
18. The method according to any one of claims 15 to 17, characterized in that the vertical position of the pressure transducer is adjusted with respect to the ratio of the density of blood to the density of the fluid forming the fluid column,Pih2= A / I-L —P2according to the formula, where / I-L the vertical displacement of the pressure sensor relative to the initial position,A / I2is the vertical displacement to be set for the transducer by the linear actuator relative to the starting position of the transducer,i is the density of the blood,p2the density of the liquid forming the liquid column.
19. The method according to any one of claims 15 to 18, characterized in that the liquid column is a sterile, heparinized saline solution.
20. The method according to any one of claims 15 to 19, characterized in that the transducer is positioned in the initial position substantially at the level of the proximal end of the guide catheter using the linear actuator, the pressure sensor is advanced to the distal end of the guide catheter, and in this position, the pressure values measured by the transducer and the pressure sensor are set to be identical.
21. The method according to any one of claims 15 to 20, characterized in that the pressure sensor is retracted to the distal end of the guide catheter using a motorized guidewire retraction unit, while continuously measuring distal pressure with the pressure sensor and aortic pressure with the transducer, and simultaneously adjusting the vertical position of the transducer in real time using the linear actuator.
22. The method according to claim 21 , characterized in that the guidewireis retracted at a constant speed or at a variable speed, and can be controlled based on anatomical conditions or medical feedback.
23. The method according to any one of claims 15 to 22, characterized in that the pressure values (Pd, Pa) measured by the pressure sensor and the transducer, and the FFR or Pd / Pa ratios or pressure gradients or other hemodynamic parameters calculated therefrom are displayed in real time on a display during retraction.
24. The method according to any one of claims 15 to 23, characterized in that the transducer is connected to the proximal end of the guide catheter via a manifold.
